Our research group is investigating single molecule science, which involves the electrical investigation of a single atom, molecule, virus, or bacterium by integrating nanotechnology, quantum metrology, artificial intelligence, and biotechnology. In particular, we are developing fifth-generation sequencing technologies to directly analyze DNA, RNA, and amino acid sequences of peptides and proteins. Our objectives are to discover new cancer biomarkers and to develop early cancer diagnostic methods using these fifth-generation sequencing technologies. Thus far, we have developed diagnostic methods for detecting cancer. Currently, we have an ongoing research projects aiming to detect small amounts of antibodies and antigens in the body based on which drugs for cancer and other intractable diseases can be developed. Our group aspires to deliver the results of our research to the world in a prompt manner to contribute to the safety, security, health, and happiness of people around the world. We conduct consistent research ranging from basic research to applied research by employing cutting-edge technologies, such as quantum computers, and collaborating with industrial partners and startup businesses.